Tech Company Financing Transactions
RevealDX Funding Round
Private investors participated in a $4.3 million capital raise for RevealDX. The financing round was announced by the company on 7/23/2024.
Transaction Overview
Company Name
Announced On
7/23/2024
Transaction Type
Venture Equity
Amount
$4,250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
1800 Westlake Ave. N 104
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Undisclosed
Website
Email Address
Overview
Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI enabled, lung cancer decision support software. Our software has been extensively validated in clinical trials and years of research. Reveal-Dx is a young company, started in early 2021, but we jump-started the company by purchasing the assets of Mindshare Medical in March. Mindshare had invested significantly over 5 years, developing core patented algorithms, validating their clinical performance, and structuring regulatory and user workflows for rapid adoption.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Wood
Chief Medical Officer
Lauren Parks
Chief Technical Officer
Michael Calhoun
Browse more venture capital transactions:
Prev: 7/23/2024: RxDiet venture capital transaction
Next: 7/23/2024: W Labs venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs